47 related articles for article (PubMed ID: 14762685)
1. Novel imidazo[1,2,4] triazole derivatives: Synthesis, fluorescence, bioactivity for SHP1.
Yan X; Zhang C; Gao LX; Liu MM; Yang YT; Yu LJ; Zhou YB; Milaneh S; Zhu YL; Li J; Wang WL
Eur J Med Chem; 2024 Feb; 265():116027. PubMed ID: 38128236
[TBL] [Abstract][Full Text] [Related]
2. SOCS-JAK-STAT inhibitors and SOCS mimetics as treatment options for autoimmune uveitis, psoriasis, lupus, and autoimmune encephalitis.
Pandey R; Bakay M; Hakonarson H
Front Immunol; 2023; 14():1271102. PubMed ID: 38022642
[TBL] [Abstract][Full Text] [Related]
3. Growth hormone inhibits the JAK/STAT3 pathway by regulating SOCS1 in endometrial cells
Li H; Sun N; Zhu Y; Wang W; Cai M; Luo X; Xia W; Quan S
Eur J Histochem; 2023 Jan; 67(1):. PubMed ID: 36546418
[TBL] [Abstract][Full Text] [Related]
4. Thymoquinone Inhibits Growth of Acute Myeloid Leukemia Cells through Reversal
Al-Rawashde FA; Johan MF; Taib WRW; Ismail I; Johari SATT; Almajali B; Al-Wajeeh AS; Nazari Vishkaei M; Al-Jamal HAN
Pharmaceuticals (Basel); 2021 Dec; 14(12):. PubMed ID: 34959687
[TBL] [Abstract][Full Text] [Related]
5. Deletion of MBD2 inhibits proliferation of chronic myeloid leukaemia blast phase cells.
Cheng L; Tang Y; Chen X; Zhao L; Liu S; Ma Y; Wang N; Zhou K; Zhou J; Zhou M
Cancer Biol Ther; 2018 Aug; 19(8):676-686. PubMed ID: 29565710
[TBL] [Abstract][Full Text] [Related]
6. SOCS1 gene promoter methylation status is associated with in-stent restenosis after percutaneous coronary intervention.
Zhou L; Wang N; Li H; Tong G; Yang J; Lai L; Pan H; Ye X; Huang J
Oncotarget; 2017 Aug; 8(34):56959-56967. PubMed ID: 28915645
[TBL] [Abstract][Full Text] [Related]
7. DNA methylation and leukemia susceptibility in China: Evidence from an updated meta-analysis.
Jiang D; Li Y; Hong Q; Shen Y; Xu C; Xu Y; Zhu H; Dai D; Ouyang G; Duan S
Mol Clin Oncol; 2016 Sep; 5(3):193-207. PubMed ID: 27588182
[TBL] [Abstract][Full Text] [Related]
8. Enhancing SHP-1 expression with 5-azacytidine may inhibit STAT3 activation and confer sensitivity in lestaurtinib (CEP-701)-resistant FLT3-ITD positive acute myeloid leukemia.
Al-Jamal HA; Mat Jusoh SA; Hassan R; Johan MF
BMC Cancer; 2015 Nov; 15():869. PubMed ID: 26547689
[TBL] [Abstract][Full Text] [Related]
9. The diagnostic value of DNA methylation in leukemia: a systematic review and meta-analysis.
Jiang D; Hong Q; Shen Y; Xu Y; Zhu H; Li Y; Xu C; Ouyang G; Duan S
PLoS One; 2014; 9(5):e96822. PubMed ID: 24810788
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic mechanisms of protein tyrosine phosphatase 6 suppression in diffuse large B-cell lymphoma: implications for epigenetic therapy.
Witzig TE; Hu G; Offer SM; Wellik LE; Han JJ; Stenson MJ; Dogan A; Diasio RB; Gupta M
Leukemia; 2014 Jan; 28(1):147-54. PubMed ID: 23979523
[TBL] [Abstract][Full Text] [Related]
11. Methylation of miR-34a, miR-34b/c, miR-124-1 and miR-203 in Ph-negative myeloproliferative neoplasms.
Chim CS; Wan TS; Wong KY; Fung TK; Drexler HG; Wong KF
J Transl Med; 2011 Nov; 9():197. PubMed ID: 22082000
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic inactivation of the hsa-miR-203 in haematological malignancies.
Chim CS; Wong KY; Leung CY; Chung LP; Hui PK; Chan SY; Yu L
J Cell Mol Med; 2011 Dec; 15(12):2760-7. PubMed ID: 21323860
[TBL] [Abstract][Full Text] [Related]
13. Identification of driver and passenger DNA methylation in cancer by epigenomic analysis.
Kalari S; Pfeifer GP
Adv Genet; 2010; 70():277-308. PubMed ID: 20920752
[TBL] [Abstract][Full Text] [Related]
14. Targeting signal transducer and activator of transcription signaling pathway in leukemias.
Benekli M; Baumann H; Wetzler M
J Clin Oncol; 2009 Sep; 27(26):4422-32. PubMed ID: 19667270
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of SHP-1 P2 promoter regulation in hematopoietic cells and its silencing in HTLV-1-transformed T cells.
Nakase K; Cheng J; Zhu Q; Marasco WA
J Leukoc Biol; 2009 Jan; 85(1):165-74. PubMed ID: 18948549
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic regulation of signal transducer and activator of transcription 3 in acute myeloid leukemia.
Ghoshal Gupta S; Baumann H; Wetzler M
Leuk Res; 2008 Jul; 32(7):1005-14. PubMed ID: 18192010
[TBL] [Abstract][Full Text] [Related]
17. Investigations into the regulation and function of the SH2 domain-containing protein-tyrosine phosphatase, SHP-1.
Tsui FW; Martin A; Wang J; Tsui HW
Immunol Res; 2006; 35(1-2):127-36. PubMed ID: 17003515
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic dysregulation of the Jak/STAT pathway by frequent aberrant methylation of SHP1 but not SOCS1 in acute leukaemias.
Chim CS; Wong AS; Kwong YL
Ann Hematol; 2004 Aug; 83(8):527-32. PubMed ID: 14762685
[TBL] [Abstract][Full Text] [Related]
19. SOCS1 and SHP1 hypermethylation in multiple myeloma: implications for epigenetic activation of the Jak/STAT pathway.
Chim CS; Fung TK; Cheung WC; Liang R; Kwong YL
Blood; 2004 Jun; 103(12):4630-5. PubMed ID: 14976049
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
